The role of Interleukin 6 inhibitors in therapy of severe COVID-19
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference179 articles.
1. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention;Wu;JAMA,2020
2. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020
3. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19;Rodríguez;J Autoimmun.,2020
4. COVID-19 revising inflammatory pathways of arthritis;Schett;Nat Rev Rheumatol.,2020
5. Coronavirus infections and immune responses;Li;J Med Virol.,2020
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Natural 7,8-secolignans from Schisandra sphenanthera fruit potently inhibit SARS-CoV-2 3CLpro and inflammation;Journal of Traditional and Complementary Medicine;2024-09
2. SARS-CoV-2 infection predisposes patients to coinfection with Staphylococcus aureus;mBio;2024-08-14
3. Harnessing immunity: Immunomodulatory therapies in COVID-19;World Journal of Virology;2024-06-25
4. The effect of levilimab on the clinical presentations and changes in inflammatory biomarkers in outpatients with mild to moderate COVID-19;Meditsinskiy sovet = Medical Council;2024-06-06
5. Achievements of rheumatology in the XXI century: contribution of Russian rheumatology;Clinical Medicine (Russian Journal);2024-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3